Provided by Tiger Trade Technology Pte. Ltd.

Harvard Bioscience

7.48
-0.0700-0.93%
Volume:10.66K
Turnover:80.02K
Market Cap:34.05M
PE:-3.18
High:7.64
Open:7.64
Low:7.37
Close:7.55
52wk High:9.40
52wk Low:3.76
Shares:4.55M
Float Shares:3.55M
Volume Ratio:0.37
T/O Rate:0.30%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.3486
EPS(LYR):-12.8000
ROE:-89.95%
ROA:1.58%
PB:4.59
PE(LYR):-0.58

Loading ...

Harvard Bioscience Q2 Call Shows Growth Amid Strain

TIPRANKS
·
Aug 20

Bio-Techne Q4 Revenue Rises 3%, Beats Estimates

Reuters
·
Aug 12

Harvard Bioscience Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 11

Harvard Bioscience Q2 Revenue Rises on Telemetry Demand, Lifts 2026 Outlook

Reuters
·
Aug 11

Harvard Bioscience Q2 Adj. EPS $(0.14) Beats $(0.21) Estimate, Sales $22.727M Beat $21.450M Estimate

Benzinga Earnings
·
Aug 11

Harvard Bioscience Q2 Net Income USD -2.91 Million

Reuters
·
Aug 11

Harvard Bioscience - Q3 2026 Guidance: Revenue $21.0-$22.60 Mln, Adj Ebitda $1.5-$2.50 Mln

THOMSON REUTERS
·
Aug 11

Harvard Bioscience Outlook FY Gross Margin 57-59%

THOMSON REUTERS
·
Aug 11

Harvard Bioscience Inc Outlook FY 2026 Revenue Growth Between 3% and 5%

THOMSON REUTERS
·
Aug 11

Top News Today/Canada: Barrick Settles Newmont Dispute, Clearing Way to List Its Gold Assets

Dow Jones
·
Aug 11

Harvard Bioscience Inc Expected to Post a Loss of 21 Cents a Share - Earnings Preview

Reuters
·
Aug 08

Harvard Bioscience Schedules Q2 Earnings Call

Reuters
·
Jul 28

Harvard Bioscience management to meet with KeyBanc

TIPRANKS
·
Jun 17

Harvard Bioscience Shareholders Expand Equity Plans, Elect Directors

TIPRANKS
·
Jun 03

Harvard Bioscience shareholders approve amended 2021 incentive plan share increase at annual meeting

Reuters
·
Jun 03

LENSAR names Michael Rossi interim CFO effective May 29

Reuters
·
May 30

Harvard Bioscience Reaffirms 2%-4% Revenue Growth for 2026; "Project Viking" Targets $4 Million in Annual Savings

Deep News
·
May 13

Harvard Bioscience Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 12

Harvard Bioscience reports Q1 adjusted EPS (33c) vs. ($1.25) last year

TIPRANKS
·
May 12

Harvard Bioscience reiterates Q2 revenue view $20.5M-$22.5M

TIPRANKS
·
May 12